(Q38028740)

English

Recent advances in novel targeted therapies for HER2-positive breast cancer

scientific article published on September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Recent advances in novel targeted therapies for HER2-positive breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1 reference

based on heuristic

inferred from title

author name string

Conleth G Murphy

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Patrick G Morris

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

1 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Anti-Cancer Drugs

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

765-776

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-08-1776

Identifiers

10.1097/CAD.0B013E328352D292

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38028740&oldid=1966934238"